Scilex Holding Company
NASDAQ: SCLXW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Henry H. Ji
- Employees
- 115
- Headquarters
- Palo Alto, United States
- IPO year
- 2021
- Market cap
- $81.7M
- Website
- https://www.scilexholding.com
Loading SCLXW…
Loading profile data…Frequently asked questions about SCLXW
What does Scilex Holding Company (SCLXW) do?
Scilex Holding Company operates as a biopharmaceutical firm primarily engaged in creating and distributing non-opioid treatments for individuals suffering from acute and chronic pain conditions. Its flagship product, ZTlido 1.8%, is a prescription-only topical lidocaine formulation designed to alleviate neuropathic pain, specifically that associ...
Where does SCLXW trade?
Scilex Holding Company (SCLXW) trades on the NASDAQ Global Market.
What sector is SCLXW in?
Scilex Holding Company (SCLXW) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Scilex Holding Company?
Henry H. Ji is the chief executive officer of Scilex Holding Company (SCLXW).
Where is Scilex Holding Company headquartered?
Scilex Holding Company is headquartered in United States.
Does SCLXW pay a dividend?
Scilex Holding Company (SCLXW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SCLXW go public?
Scilex Holding Company (SCLXW) completed its initial public offering in 2021.